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ABSTRACT
The -1 programmed ribosomal frameshifts (PRF),
which are used by many viruses, occur at a
heptanucleotide slippery sequence and are cur-
rently thought to involve the tRNAs interacting with
the ribosomal P- and A-site codons. We investigated
here whether the tRNA occupying the ribosomal E
site that precedes a slippery site influences -1 PRF.
Using the human immunodeficiency virus type 1
(HIV-1) frameshift region, we found that mutating the
E-site codon altered the -1 PRF efficiency. When the
HIV-1 slippery sequence was replaced with other
viral slippery sequences, mutating the E-site codon
also altered the -1 PRF efficiency. Because HIV-1 -1
PRF can be recapitulated in bacteria, we used a
bacterial ribosome system to select, by random
mutagenesis, 16S ribosomal RNA (rRNA) mutations
that modify the expression of a reporter requiring
HIV-1 -1 PRF. Three mutants were isolated, which
are located in helices 21 and 22 of 16S rRNA, a
region involved in translocation and E-site tRNA
binding. We propose a novel model where -1 PRF is
triggered by an incomplete translocation and
depends not only on the tRNAs interacting with the
P- and A-site codons, but also on the tRNA
occupying the E site.
INTRODUCTION
The -1 programmed ribosomal frameshift (PRF) is a non-
conventional translation phenomenon that pertains to a
particular change in the reading frame of the messenger
RNA (mRNA) induced by a stimulatory signal. This
strategy is mainly used by viruses to synthesize the
precursor of their enzymes and to maintain a speciﬁc
ratio between structural and enzymatic proteins (1). In
addition, -1 PRF is used during the translation of some
prokaryotic and eukaryotic mRNAs (2). One of the best-
known examples of -1 PRF occurs when ribosomes
translate the full-length mRNA of the human immuno-
deﬁciency virus type 1 (HIV-1) (3–5). A -1 PRF is induced
by two cis-elements within the mRNA: a slippery
heptanucleotide X XXY YYZ (X is any nucleotide, Y is
either A or U and Z is not a G in eukaryotes; spaces
indicate the initial reading frame), where the -1 PRF
occurs, and a following speciﬁc RNA secondary structure,
the so-called stimulatory signal. This RNA structure is
often a pseudoknot (4) but can also be a stem–loop, as it is
the case for HIV-1 (6–8), or a three-way stem–loop, as
found in bacterial insertion sequences (9,10). The stimu-
latory signal controls the -1 PRF eﬃciency by making the
ribosome pause over the slippery sequence (11–13).
However, pausing itself is not suﬃcient to promote -1
PRF (14), and it was proposed that the stimulatory signal
has a speciﬁc interaction with the ribosome. Altering
the -1 PRF eﬃciency impairs viral replication (15–17) and
it has been observed that even a small change in -1 PRF
eﬃciency substantially handicaps the replication capacity
of HIV-1 (18). This indicates that the -1 PRF event could
serve as a target for the design and development of new
antiviral drugs. It is thus important to fully understand
the -1 PRF mechanism.
Several mechanistic models have been discussed in the
literature to account for -1 PRF. Initially, Jacks et al. (19)
proposed a model of simultaneous slippage of the
peptidyl-tRNA (pept-tRNA) and the aminoacyl-tRNA
(aa-tRNA). In this model (Figure 1A), pept-tRNA and
aa-tRNA bound respectively to the XXY and YYZ
codons in the ribosomal P/P and A/A sites unpair from
the mRNA (the ﬁrst and second letters represent,
respectively, binding sites on the small and the large
ribosomal subunit). The tRNAs and the ribosome shift
towards the 5’ direction and re-pair to the mRNA in the
new reading frame. The Jacks et al. model has been
criticized because it ignores the fact that peptide bond
formation, which occurs very rapidly (20–22), leaves not
much time for the shift to occur after the accommodation
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et al. model had been provided by Plant et al. (23), who
suggested that a movement of 9A ˚ of the anticodon loop of
the aa-tRNA upon occupancy of the A/A site creates a
tension on the mRNA because of the resistance to
unwinding of the stimulatory signal. This tension would
be relieved by the unpairing of the tRNAs, slippage of the
mRNA by one base in the 30 direction and re-pairing of
the tRNAs in the new reading frame. However, the
proposed 9A ˚ displacement of the anticodon loop of the
aa-tRNA is not supported by structure analysis and by
large-scale molecular dynamics (24,25). A second model
was proposed by Weiss et al. (26), where -1 PRF occurs
during the translocational step of the elongation cycle.
Translocation proceeds in a stepwise manner and requires
conformational changes within the ribosome (27–31). In a
simpliﬁed way, after peptide bond formation, the acceptor
stem of the newly deacylated-tRNA (deac-tRNA) and of
pept-tRNA move, respectively, from the P to E site and
from the A to P site of the large ribosomal subunit. The
resulting positions of both tRNAs are thus described as
the P/E and A/P sites, respectively. In the next step, the
anticodon stem–loop of the tRNAs moves to the E and P
sites on the small ribosomal subunit, dragging the mRNA
by one codon (32,33). Weiss et al. (26) suggested that,
when the tRNAs occupy these P/E and A/P sites, they can
unpair from the mRNA, move in the 30 direction with
the ribosome and re-pair in the new reading frame. The
anticodon stem–loops of the tRNAs then move with the
mRNA to the E and P sites of the small ribosomal subunit
(Figure 1B). The analysis of an electron cryo-microscopy
(cryo-EM) ribosome-mRNA pseudoknot complex stalled
Figure 1. Models discussed in the literature to account for -1 PRF. The ribosomal subunits, the stimulatory signal (represented here by a stem–loop),
the classic slippery sequence (X XXY YYZ) and the ribosomal sites (E, P and A sites) occupied by the corresponding tRNAs are indicated.
The deac-tRNA, pept-tRNA and aa-tRNA are, respectively, shown in green, pink and blue, and coloured circles represent amino acids attached to
the 30 end of tRNAs. Elongation factors were omitted from the ﬁgure. (A) The two-tRNA simultaneous slippage model as proposed by Jacks et al.
(19) and reﬁned by Plant et al. (23): the -1 PRF occurs when the pept-tRNA and the aa-tRNA occupy, respectively, the P/P and the A/A sites, prior
to peptide bond formation. (B) Model proposed by Weiss et al. (26), in which the -1 PRF occurs after peptide bond formation, when the deac-tRNA
and the pept-tRNA occupy, respectively, the P/E and A/P sites. It should be noted that the relative position of the subunits is modiﬁed (ratchet-like
rotation) compared to their position after peptide bond formation (27). (C) Model initially proposed by Farabaugh (38) and experimentally
supported by Le ´ ger et al. (35), in which the -1 PRF occurs before peptide bond formation and occupancy of the A/A site, when the incoming
aa-tRNA occupies the A/T entry site. This model is updated so as to include the deac-tRNA in the E site, which is ejected from the ribosome when
the aa-tRNA occupies the A/A site (60).
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event occurs during translocation (34), by showing that
the elongation factor EF2 (eEF2), the eukaryotic homo-
logue of EF-G, is bound to the stalled complex. However,
it was observed that -1 PRF can be aﬀected by mutations
in the small subunit rRNA that alter the accommodation
of the aa-tRNA in the A/A site (35) as well as by
mutations in the elongation factor 1A (eEF1A) (36,37),
the eukaryotic homologue of EF-Tu, that contributes to
the accommodation process. These observations cannot
be explained by any of the two previous models, but they
are taken into account by a third model, which was
initially proposed by Farabaugh (38) and further sup-
ported by experimental data from our group (35). This
model proposes that the -1 PRF occurs when aa-tRNA
and pept-tRNA are located, respectively, in the A/T entry
site and in the P/P site (Figure 1C). Under these
conditions, the -1 PRF has more time to take place,
compared to the model of Jacks et al. Still, some
observations related to -1 PRF cannot be explained by
this model. In particular, swapping a fragment of eight
nucleotides located immediately 5’ from the slippery
sequence in the HIV-1 frameshift region with the
corresponding fragment in the human T-cell leukaemia
virus type 2 (HTLV-2) was found to decrease -1 PRF
eﬃciency (39).
In this study, we reveal additional aspects that are
important for -1 PRF, using the HIV-1 frameshift region
as a model. In HIV-1, the slippery sequence is U UUU
UUA (40) and the stimulatory signal is a two-stem helix,
where an internal three-nucleotide bulge separates the
lower stem from the upper stem–loop (6–8) (Figure 2).
This signal is separated from the slippery sequence by one
nucleotide. We previously suggested that the lower stem
favours a speciﬁc interaction between the upper stem–loop
and the ribosome, when the stimulatory signal ﬁrst
encounters the ribosome. After this ﬁrst contact, the
ribosome progresses along the mRNA and unwinds
the lower stem. Once the slippery sequence occupies the
decoding site, the upper stem–loop, which is at a distance
of eight nucleotides from this slippery sequence, acts as the
eﬀective frameshift stimulatory signal. It allows the -1
PRF to occur, involving the tRNAs interacting with the P-
and A-site codons. With use of a dual-luciferase reporter
system in which the HIV-1 frameshift region was inserted
between the coding sequences for the Renilla (Rluc) and
ﬁreﬂy luciferase (Fluc) such that the Fluc expression
requires the -1 PRF of HIV-1, we demonstrated that
mutations in the E-site codon can alter the -1 PRF
eﬃciency. The same observation was made for other viral
slippery sequences. In addition, since we had recently
shown that the -1 PRF of HIV-1 can be recapitulated in
Escherichia coli and that prokaryotic ribosomes respond
in the same manner as eukaryotic ribosomes to mutations
in the HIV-1 frameshift stimulatory signal (35), we used a
-1 PRF system harboured in E. coli to undertake a
random search of mutations in 16S rRNA that aﬀect -1
PRF. We found three mutations of this kind, all located in
the platform region of the small ribosomal subunit. This
region is positioned close to the binding site of the E-site
tRNA (41) and is known to be involved in conformational
changes of the ribosome during translocation (27,28,31).
Based on these ﬁndings, we propose a novel model in
which -1 PRF is triggered by an incomplete translocation
and requires the slippage of not only the tRNAs
interacting with the P- and A-site codons, but also of
the tRNA occupying the E site.
MATERIALS AND METHODS
Plasmid constructions
All primers used to generate constructs were purchased
from Integrated DNA Technologies Inc. (Coralville, IA,
USA). Plasmids used in frameshift assays in mammalian
cultured cells are derivatives of pDual-HIV (–1) and
(0) plasmids described in Dulude et al. (18). The pDual-
HIV (–1) plasmid contains the HIV-1 group M subtype
B frameshift region inserted between the sequences coding
for Rluc and Fluc, such that the Fluc coding sequence is in
the –1 reading frame relative to the Rluc initiator codon.
In pDual-HIV (0), Fluc is in frame with the Rluc initiator
codon, by addition of an adenine 30 adjacent to the
slippery sequence, which is inactivated by mutagenesis to
C UUC CUC. The Rluc expression is used to normalize
the Fluc expression. The -1 PRF eﬃciency of each (–1)
construct is obtained by dividing the Fluc/Rluc ratio by
the corresponding ratio of the (0) frame construct
(Figure 2). The M1 to M7 mutants and C1 to C6
constructs were generated by ampliﬁcation of the mutated
DNA from pDual-HIV (–1), with use of standard PCR
procedures and a primer spanning the KpnI site, 50-GCA
GGGGGTACCTGGAAAGGAAGGACACCAAATGA
AAGATTGTTCGAGAGACAGGCNNNNNNNNNNG
GGAAGATCTGG-30, (N corresponds to the mutated
Figure 2. HIV-1 frameshift region in eukaryotic and prokaryotic dual-
luciferase systems. Plasmids contain the HIV-1 frameshift region
inserted between the coding sequence of the Rluc (white) and the
Fluc (grey) genes, as described in Dulude et al. (18). The HIV-1 slippery
sequence is underlined. The HIV-1 two-stem helix frameshift stimula-
tory signal (6–8) and the restriction sites (KpnI and Pﬂ23II) used in this
study are indicated. The insertion of the HIV-1 frameshift region is
such that the Fluc coding sequence is in the -1 reading frame relative to
the Rluc AUG initiator codon (-1 constructs). For the (0) frame
construct, the slippery sequence is inactivated by mutagenesis to
C UUC CUC and an A is inserted 30 to the slippery sequence, such that
the Fluc coding sequence is in-frame with the Rluc AUG initiator
codon. The Fluc gene is always expressed as a fusion protein with Rluc.
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primer spanning the Pﬂ23II site, 50-GCCAACCGA
ACGGACATTTCG-30, for the forward and reverse
reactions, respectively. The mutated DNA was subcloned
into pDual-HIV (–1) previously digested by KpnI and
Pﬂ23II restriction enzymes.
Mutations in 16SrRNA (G666, iC739 and G604A)
were selected with a specialized bacterial ribosome system
(42,43), using the p3RGFP-HIV (–1) plasmid, described in
details elsewhere. Brieﬂy, p3RGFP-HIV (–1) contains the
E. coli rrnB operon under the control of the inducible
lacUV5 promoter, as well as two reporter genes coding for
the red (RFP) and green (GFP) ﬂuorescent proteins. The
DsRed T4 plasmid coding for RFP was a generous gift
from Dr B.S. Glick, from the University of Chicago (44),
and the GFP coding sequence was obtained from the
pGFPemd-N1 plasmid, a kind gift from Dr M. Bouvier,
from the Universite ´ de Montre ´ al. RFP is expressed by
conventional translation whereas the HIV-1 frameshift
region is inserted in the beginning of the coding sequence
of GFP, so that its expression requires a –1 PRF. The
ribosome-binding sites (RBS) of the reporters are changed
to 50-AUCCC and the messenger-binding site (MBS) of
the 16S rRNA is changed to 50-GGGAU, so that the
reporters are exclusively translated by the ribosomes that
contain the plasmid-encoded 16S rRNA (GFP/RFP
system). Mutations iG666 and C739 were introduced
in the 16S rRNA by ampliﬁcation of the mutated DNA
fragments from p3RGFP-HIV (–1) with a two-step PCR
approach encompassing restriction sites BlnI and DraIII,
using an overlap extension procedure (45). The resultant
PCR fragment was subcloned into p3RGFP-HIV (–1)
previously digested with the same enzymes.
The specialized bacterial dual-luciferase system was
created as follows: the Rluc to Fluc coding sequence
encompassing the HIV-1 frameshift region in pDual-HIV
(–1) and (0) constructs was ampliﬁed by PCR, using the
primer spanning the NsiI site, 50-CTAGAGCCACC
ATGCATACCAGCAAGG-30, and the primer spanning
the Pﬂ23II site, 50-GTTTCATAGCTTCTGCCAACC
GAACG-30, for the forward and reverse reactions,
respectively. The resultant PCR fragments were subcloned
into the pRNAluc2 plasmid digested with NsiI and
Pﬂ23II, as described in Be ´ langer et al. (42), generating
pDual-HIV/P (0) and (–1) plasmids (where P stands for
prokaryote plasmids). The pRNAluc2 plasmid contains
the E. coli rrnB operon under the control of the inducible
lacUV5 promoter and a reporter gene coding for Fluc.
As in the GFP/RFP system, the RBS of the dual-luciferase
reporter and the MBS of the 16S rRNA were mutated so
that the dual-luciferase reporter is exclusively translated
by ribosomes that contain plasmid-encoded 16S rRNA.
The 16S rRNA mutations in p3RGFP-HIV (–1) (G666,
iC739, G604A, iG666 and C739) were cloned in pDual-
HIV/P (0) and (–1), using two ApaI restriction sites.
Randommutagenesis of 16SrRNA
Random mutations were introduced into the 16S rRNA
fragment using a high-copy plasmid (pUC18, Fermentas).
A BamHI–SacI fragment encompassing 16S rRNA from
p3RGFP-HIV (–1) was cloned into pUC18 digested with
the same enzymes, generating pUC18/16S. E. coli XL1-
Red mutator strain (Stratagene) was used to produce
random mutations into 16S rRNA. Escherichia coli XL1-
Red competent cells were transformed with pUC18/16S as
directed by the manufacturer to obtain randomly mutated
plasmids (pUC18/R16S, where R stands for randomized
16S rRNA) (46,47). The procedure was repeated seven
times, so that more than 90% of the clones analysed
contained a mutation in the 16S rRNA fragment.
A second BlnI restriction site located in the beginning of
the gene coding for 23S rRNA in p3RGFP-HIV (–1) was
mutated to an AﬂII restriction site, using a standard
mutagenesis procedure, so as to conserve a unique BlnI
restriction site in the 16S rRNA gene. The 16S rRNA
random mutant library from pUC18/R16S was cloned
into p3RGFP-HIV (–1), using BlnI–DraIII restriction
sites, which generated p3RGFP-HIV/R16S. Each isolated
16S rRNA mutation was re-introduced into p3RGFP-
HIV (–1) to verify that the phenotype was conserved.
Frameshift assays inmammalian cultured cells
Frameshift assays in eukaryotes were monitored by
transient transfection of the dual-luciferase plasmids
(pDual-HIV derivatives) into human embryonic kidney
293T cells (HEK293T) maintained in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) supplemented with 10% (v/v)
FBS (Wisent), with 2 10
5 cells/well seeded in 6-well
plates. Two mg of plasmids were diluted in 3% of the
initial culture volume in fresh serum-free medium and
mixed with an equivalent volume containing 5mg of PEI
(polyethylenimine, Polysciences Inc.). The mixture was
incubated for 15min at room temperature prior to the
addition to cell culture. Cells were cultured for 48h before
being washed twice with 2ml of PBS, and lysed with 450ml
of the Cell Passive Lysis Buﬀer 1X (Promega). Fluc versus
Rluc activities of each construct were measured for 10s as
relative light units (RLU) with an EG&G Berthold Lumat
LB 9507 luminometer, using a non-commercial dual-
luciferase enzyme assay system (48).
Bacterial frameshift assays
Dual-luciferase and GFP/RFP assays in E. coli were
conducted as follows: overnight cultures of E. coli Top 10
strain (Invitrogen) were transformed with pDual-HIV/P
or p3RGFP-HIV derivatives. Plasmids were grown in LB
containing 100mg/ml of ampicillin at 378C. The cultures
were diluted to an absorbance of 0.1at 600nm and
incubated for 1h at 378C. The plasmid-encoded rRNA
expression was induced with 1mM of isopropyl-b-D-
thiogalactopyra noside (IPTG) for 3h for dual-luciferase
assays, and 6h for GFP/RFP assays at 378C. The dual-
luciferase assays were carried as the luciferase assays
described in Be ´ langer et al. (42), except that the cells were
lysed with 50ml of the Cell Passive Lysis Buﬀer 1X and
incubated for 15min at room temperature. Fluc and Rluc
activities were measured as described above. For GFP/
RFP assays, 1ml of cultured cells was centrifuged. The
pellet was washed three times with 500ml of PBS and re-
suspended in 200ml of PBS. Fluorescence was measured
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a-FP, Packard) at a 485nm excitation wavelength
(bandpass: 20nm) for both GFP and RFP and at a
535nm (bandpass: 25nm) and 580nm (bandpass: 15nm)
emission wavelength for GFP and RFP, respectively.
RESULTS
Modulating role in -1PRF of thethree nucleotides
immediately upstream of theHIV-1 slippery sequence
As mentioned earlier, mutations within the eight nucleo-
tides immediately preceding the slippery sequence can
aﬀect the eﬃciency of -1 PRF (39). We may expect that the
closer a nucleotide of this region is to the slippery
heptamer X XXY YYZ, the higher its inﬂuence on -1
PRF. In this study, we focused on the three nucleotides
positioned immediately upstream of the slippery hepta-
mer, which we name A, B and C. Together with the
slippery heptamer, these nucleotides form the decamer
A BCX XXY YYZ, which we call the extended slippery
sequence. In the last model describing -1 PRF [Figure 1C,
(35,38)], the XXY and YYZ codons of the classic slippery
sequence (X XXY YYZ) are located in the P and A sites,
respectively, when the -1 PRF occurs. The A BC
nucleotides that are directly upstream of the slippery
sequence are positioned such that the BCX and the ABC
codons are located, respectively, in the E site before and
after the shift. To investigate whether the identities of
nucleotides A BC can aﬀect the -1 PRF, we studied seven
mutants of the frameshift region of HIV-1, in which the
A BC nucleotide sequence (U AAU UUU UUA), was
replaced by the corresponding sequence found in other
viruses. We used a dual-luciferase reporter system (18)
in mammalian cultured cells. In this system, the HIV-1
frameshift region is positioned between Rluc and Fluc
coding sequences, such that Fluc expression requires the
–1 PRF of HIV-1. In Figure 3A, one sees the extended
slippery sequences of the wild-type HIV-1 (WT; U AAU
UUU UUA) and of seven mutants numbered from M1 to
M7. The M1 mutant corresponds to a variant isolated
from a protease inhibitor-exposed patient, and M2 is a
natural variant of HIV-1 (49). In M3 to M7 mutants,
nucleotides A BC are taken from HIV type 2 (HIV-2; M3),
the giardia virus (M4), the severe acute respiratory
syndrome coronavirus (SARS-CoV; M5), the human
T-cell lymphotropic virus type 1 (HTLV-1; M6) and the
equine infectious anaemia virus (EIAV; M7). The absolute
value of the WT -1 PRF eﬃciency was 8.0 1.0%. In
Figure 3B, a value of 100% is arbitrarily assigned to this
eﬃciency, and the eﬃciencies of all mutants are shown
relative to WT. Among all investigated mutants, M1 is
characterized by the lowest level of -1 PRF eﬃciency,
which is only 5% of the WT level. Such a drop of the
eﬃciency can be explained by the fact that M1 is the only
variant in which the re-pairing of the pept-tRNA in the
new reading frame is not allowed and this variant is most
likely very poorly infectious. With M2, M5, M6 and M7
mutants, the -1 PRF eﬃciency was increased by about
50%. In contrast, with M3, the -1 PRF eﬃciency
decreased slightly to 70% of the wild-type value, while
the frameshift level remained unchanged with M4.
Although the eﬀects are not dramatic, they are all
signiﬁcant and well-reproducible [with M1, M2, M6 and
M7 mutants; P values are 0.0001 (n54) and with M5
mutant, P-value is 0.001 (n=4), as determined by
Student’s t-test]. To verify whether the -1 PRF could be
also inﬂuenced by mutations upstream the A BC nucleo-
tides, we mutated the GCU codon, which is immediately
upstream the BCX codon (GCU was exchanged with
AAU, UCU, GGU or CAU, so that the A position
remained unchanged). These mutations did not alter the -1
PRF eﬃciency (data not shown). We can conclude that
mutations in positions A BC, immediately upstream of the
classic slippery sequence, can noticeably aﬀect the -1 PRF
eﬃciency of HIV-1 and, therefore, that the nucleotides
located at positions A BC could be involved in the -1 PRF
of HIV-1. This was not the case for the nucleotides
upstream of A BC.
-1PRF efficiencies withother viral frameshift regions
mutated atpositions A BC
We next investigated whether the identity of the A BC
nucleotides is also important for -1 PRF with other viral
slippery sequences. To test this, we created various
constructs in which the extended slippery sequence of
HIV-1 (U AAU UUU UUA) was replaced with other
extended viral slippery sequences. The two-stem helix of
Figure 3. Eﬀect of mutating the three nucleotides upstream of the
HIV-1 slippery sequence on the -1 PRF eﬃciency. (A) The nucleotides
forming the wild-type extended HIV-1 slippery sequence are indicated
(U AAU UUU UUA, corresponding to A BCX XXY YYZ; the spaces
refer to the initial reading frame). (B) -1 PRF eﬃciencies of the M1
to M7 mutant constructs (shown in light grey) are indicated relative
to wild-type (WT, shown in black) set arbitrarily at 100%. -1 PRF
eﬃciencies were obtained from dual-luciferase activities with pDual-
HIV derivatives in 293T mammalian cultured cells. The values are the
means of at least four independent experiments, with the bars
representing the standard error on the means.
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slippery sequences, which were assayed in the eukaryotic
dual-luciferase system described above and are shown in
Figure 4A. The C1, C3 and C5 constructs contain the
extended slippery sequences found, respectively, in giardia
virus (C AUC CCU UUA), EIAV (U CCA AAA AAC)
and in SARS-CoV (G UUU UUA AAC). The -1 PRF
eﬃciencies obtained with these three constructs vary
between 4% and 5%, about 40–60% of the HIV-1 -1
PRF eﬃciency (Figure 4B). The nucleotides at positions
A BC in each of the C1, C3 and C5 constructs were
mutated to UAA, the nucleotides found at positions A BC
upstream of the classic slippery sequence of HIV-1,
generating the C2, C4 and C6 chimeric constructs.
This decreased -1 PRF eﬃciency by about 50%,
compared to the C1, C3 and C5 constructs, which
conﬁrms the observations made with HIV-1 slippery
sequence concerning the importance of nucleotides A BC
for -1 PRF.
It was previously demonstrated that exchanging slip-
pery sequences from diﬀerent frameshift regions alters the
-1 PRF eﬃciency (18,50). However, in these studies, only
the heptanucleotide slippery sequence was exchanged.
Figure 4B also compares the eﬀect of exchanging either
the classic or the extended HIV-1 slippery sequence with
other viral slippery sequences on -1 PRF eﬃciency. When
the classic slippery sequence of HIV-1 is replaced with the
classic slippery sequence of giardia virus, EIAV or that
of SARS-CoV, the -1 PRF eﬃciency drops to 20–30%
when compared to HIV-1 -1 PRF eﬃciency. When the
HIV-1 extended slippery sequence is replaced with the
extended slippery sequence found in giardia virus, EIAV
or in SARS-CoV, the -1 PRF eﬃciency also decreases,
but much less than when the substitution involves only
the classic heptamer, being 50–60% of HIV-1 -1 PRF
eﬃciency. These results conﬁrm that exchanging slippery
sequences alters the -1 PRF eﬃciency, and, in addition,
shows that the extent of the decrease depends upon
whether the extended slippery sequence or only the classic
slippery sequence is exchanged. These results also conﬁrm
the importance of positions A BC for -1 PRF.
Identification of16SrRNA mutations that affectHIV-1 -1
PRF efficiency
We also attempted to identify rRNA mutants that could
interfere with the -1 PRF of HIV-1. So far, the rRNA
mutations that were found to inﬂuence -1 PRF perturb the
accommodation process (35). Our aim was to select
mutations that inﬂuence -1 PRF by aﬀecting the E-site
tRNA binding, since we had found that mutations in the
E-site codon can alter -1 PRF. Our strategy consisted in
using the bacterial ribosome and introducing random
mutations in 16S rRNA with the high-mutation-rate
E. coli XL1-Red mutator strain (see Materials and
Methods section for details). A pool of randomly mutated
plasmids was obtained, where 90% of the clones analysed
contained a mutation in the 16S rRNA. This 16S rRNA
random library was then cloned into a plasmid containing
reporter genes coding for RFP and GFP, in which RFP is
expressed by conventional translation, whereas GFP
expression requires the -1 PRF of HIV-1. The RBS of
the reporters and the MBS site of the 16S rRNA random
library are mutated and remain complementary, so that
the reporters are exclusively translated by ribosomes that
contain plasmid-encoded 16S rRNA. A small screen was
individually performed (about 2000 clones), using the
GFP/RFP assay to select clones for which GFP expression
was aﬀected but for which conventional translation was
only moderately decreased (<50%). Three mutants were
selected: mutant G666 with a guanosine deleted from the
stretch of guanosines between positions 666 to 671,
mutant iC739 with a cytosine inserted into the stretch of
cytosines between positions 735 to 739, and mutant
G604A with guanosine 604 replaced by an adenosine.
Figure 5A shows the variations in HIV-1 -1 PRF eﬃciency
obtained with each selected mutant relative to wild-type
16S rRNA, which was set arbitrarily at 100%, based on
Figure 4. -1 PRF eﬃciencies obtained with various slippery sequences.
The HIV-1 slippery sequence is replaced with slippery sequences from
other viral frameshift regions. The stimulatory signal of HIV-1 is used
in all constructs. (A) The nucleotides forming the extended HIV-1
slippery sequence (U AAU UUU UUA, corresponding to A BCX
XXY YYZ; the spaces refer to the initial reading frame) are shown.
The C1, C3 and C5 constructs contain the extended slippery sequences
found, respectively, in the frameshift region of giardia virus (C AUC
CCU UUA), EIAV (U CCA AAA AAC) and SARS-CoV (G UUU
UUA AAC). Positions A BC in the C2, C4 and C6 chimeras are
mutated to U AA, the nucleotides found at positions A BC in the
extended slippery sequence of HIV-1. (B) -1 PRF eﬃciencies obtained
from dual-luciferase activities with pDual-HIV derivatives in 293T
mammalian cultured cells. The -1 PRF eﬃciencies with the C1 to C6
constructs are indicated relative to HIV-1 wild-type frameshift region,
which is set arbitrarily at 100%. Constructs containing a C CCU UUA,
A AAA AAC and a U UUA AAC heptanucleotide sequence are shown
in dark grey, light grey and in white, respectively. The values are the
means of at least four independent experiments, with the bars
representing the standard error on the means.
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mildly (to 80%), whereas G604A and iC739 increased -1
PRF eﬃciency to 130 and 200%, respectively. We also
created a bacterial dual-luciferase vector, similar to the
one used in mammalian cultured cells, but in which the
dual-luciferase reporter is exclusively translated by ribo-
somes containing the plasmid-encoded 16S rRNA. The
16S rRNA mutants were introduced in this vector and -1
PRF eﬃciencies were assessed from measurements of
luciferase activities. With mutant G604A and iC739, the -1
PRF eﬃciency was increased to about 170%. However,
surprisingly, the -1 PRF eﬃciency was also increased to
150% with mutant G666, despite the fact that it
decreased in the GFP/RFP assay. This discrepancy
between the GFP/RFP and the bacterial dual-luciferase
assay could result from the fact that the HIV-1 frameshift
region is located at a short distance from the AUG
initiator codon of the GFP reporter in the GFP/RFP
system, and that the two reporters are translated
separately. In the dual-luciferase assay, the HIV-1 frame-
shift region is inserted between the two reporter genes, so
that the Fluc reporter, whose expression requires the -1
PRF of HIV-1, is synthesized as a Rluc-fusion protein.
Although entirely hypothetical, one can propose that the
changes in the -1 PRF eﬃciency triggered by the G666
mutant could cause a drop-oﬀ of the short peptide
resulting from the -1 PRF, with the GFP/RFP system.
This could cause an apparent decrease in -1 PRF
eﬃciency, a situation that does not occur with the dual-
luciferase system. Because the G666 and iC739 mutants
are located in either strand of the same 16S rRNA helix,
we used a standard PCR procedure to create the inverse
mutation: iG666 and C739. While iG666 had no eﬀect
on the -1 PRF eﬃciency in both GFP/RFP and dual-
luciferase assays (data not shown), C739 increased the -1
PRF eﬃciency to 160 and 230%, respectively, in both
assays. We further investigated whether the 16S rRNA
mutations also increase -1 PRF eﬃciency when combined
with other slippery sequences. The iC739 mutation was
investigated with the C5 construct that contains the
extended slippery sequence found in SARS-CoV and the
C6 chimeric construct, where the classic slippery sequence
of HIV-1 is replaced with the one found in SARS-CoV,
whereas the A BC nucleotides correspond to those found
in HIV-1, as described in Figure 4A. As with the HIV-1
frameshift region, the iC739 mutation increased -1 PRF
eﬃciency with the other frameshift regions to about 150%
compared to wild-type 16S rRNA. The locations of the
mutations that were selected from the random library are
shown in the secondary and tertiary structure of the 16S
rRNA (Figure 6). G666, iG666, C739 and iC739 are
located in helix 22 whereas G604A is located in helix 21 of
the 16S rRNA. Helices 21 and 22 are part of the central
domain of the 16S rRNA, a region that forms the 30S
subunit platform and participates in E-tRNA binding
(see subsequently).
Figure 6. Localization of the 16S rRNA mutations that alter HIV-1 -1
PRF eﬃciency. (A) Scheme of E. coli 16S rRNA secondary structure
(65). The central domain is enlarged and coloured. Portions of the
sequences of helices 21 and 22 are indicated in orange and green,
respectively. The 16S rRNA mutations within helices 21 (G604A)
and 22 (G666, iC739 and C739) that aﬀect -1 PRF are boxed.
The 690 and 790 loops interacting with the E-site tRNA are indicated.
(B) E. coli 16S rRNA tertiary structure [ﬁgure made with Pymol (66)]
as seen in the crystal structure of the 30S ribosomal subunit
[PDB accession code 2AVY, (67)]. The central domain and helices 21
and 22 are coloured as in A. The 16S rRNA mutations are represented
in spaced ﬁlling and in red.
Figure 5. 16S rRNA mutations aﬀecting -1 PRF eﬃciency. (A) -1 PRF
eﬃciencies were measured from GFP/RFP and dual-luciferase assays as
described in the text, with HIV-1 extended slippery sequence. -1 PRF
eﬃciencies are expressed as a percent of wild-type (WT) 16S rRNA
activity. (B) -1 PRF eﬃciencies with other slippery sequences: C5 and
C6 constructs (see description in Figure 4A). -1 PRF eﬃciencies were
measured from dual-luciferase assays and are expressed as a percent of
wild-type (WT) 16S rRNA activity. -1 PRF eﬃciencies are the means of
at least three independent experiments, with the bars representing the
standard error on the means.
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Using a dual-luciferase assay in mammalian cultured cells,
we demonstrated that mutating the BCX codon plus the
preceding base (A) immediately upstream of HIV-1 classic
heptanucleotide slippery sequence aﬀects the -1 PRF
eﬃciency. The BCX and the ABC codons occupy,
respectively, the E site before and after the -1 PRF. We
found that mutating the ABC nucleotides, located at the
same position upstream of other viral slippery sequences
also changes the -1 PRF eﬃciency. Interestingly, from the
analysis of 41 eukaryotic virus slippery sequences retrieved
from the RECODE database (Table 1) (51), we observed
that there is a bias in the identity of the BCX codon
located upstream of various slippery sequences: there may
be diﬀerent codons located immediately upstream of a
given classic slippery sequence, but they appear to be
exclusive for this slippery sequence, e.g. CCU and UUU
codons are both found upstream of the slippery sequence
U UUA AAC, but are not found upstream of any other
viral slippery sequence (Table 1). No such bias is observed
with the codon immediately 5’ to this upstream codon.
This observation is in agreement with our ﬁndings that
mutating the E-site codon changes the -1 PRF eﬃciency,
which is not the case when changing the codon 5’ to the
E-site codon.
Using a specialized bacterial ribosome system, we also
showed that mutations located in helices 21 and 22 of the
16S rRNA, in the platform region of the small ribosomal
subunit, increase HIV-1 -1 PRF eﬃciency (Figure 5).
From the analysis of the ribosome crystal structure
(41,52), it can be inferred that these mutations could
inﬂuence the structure of a region involved in the binding
of the tRNA at the E site (Figure 6). Indeed, the mutations
located in helix 22 are close to nucleotides from the
690 and 790 loops that contact the anticodon stem of the
tRNA at the E site. These interactions require kink-turn
motifs that are maintained by the coaxial helices 21 and
22. Therefore, the mutations that alter the -1 PRF
eﬃciency could be related to the E site. Interestingly,
mutations in the small subunit ribosomal proteins S7 and
S11, which are located in proximity to the E site, have
been found to increase spontaneous frameshift (53),
further supporting a relationship between this region
and frameshift. When 16S rRNA mutations were assessed
with diﬀerent combinations of classic slippery sequences
and upstream triplets (ABC positions), the -1 PRF
eﬃciency increased to the same extent. Moreover, the
platform region is involved in conformational changes
during translocation (27,28,30,31). The 16S rRNA
mutants could alter -1 PRF eﬃciency, not only by
inﬂuencing the binding of tRNA at the E site, but
also by interfering with translocation. It is worth
mentioning that a 23S rRNA C2394G mutation, that
aﬀects translocation, increases spontaneous frameshift
(54), which also supports a relationship between translo-
cation and frameshift. Also, cycloheximide, a transloca-
tion inhibitor (55), was found to increase HIV-1 -1 PRF
eﬃciency by about 2-fold (our unpublished data), which
supports the involvement of translocation in -1 PRF.
From previous observations and our own results, we
propose a reﬁnement of the last model describing -1 PRF.
In this novel model (Figure 7), the sequence of events that
lead to -1 PRF starts when the BCX and XXY codons
Table 1. Analysis of the slippery sequence from diﬀerent viral
frameshift regions
Virus Extended version of slip-
pery sequences
Human immunodeﬁciency virus type 1 G GCUA A U UUU UUA
Simian immunodeﬁciency virus G GCAA A U UUU UUA
Human immunodeﬁciency virus type 2 G GCAG G U UUU UUA
Rous sarcoma virus C UUGA C A AAU UUA
Saccharomyces cerevisiae virus L-A U CAGC A G GGU UUA
Giardia virus C GCCA U C CCU UUA
Gill-associated virus G AGGC A A AUU UUC
Human T-cell lymphotropic virus type 2
(gag/pro)
CU G AG G A AAA AAC
Bovine leukaemia virus (gag/pro) C AAAU C A AAA AAC
Mouse mammary tumour virus (gag/pro) A AAUU C A AAA AAC
Equine infectious anaemia virus U GUUC C A AAA AAC
Human T-cell lymphotropic virus type 1
(gag/pro)
AC A CC C A AAA AAC
Simian T-cell lymphotropic virus type 1
(gag/pro)
AC A CC C A AAA AAC
Human astrovirus G GCCC C A AAA AAC
Porcine reproductive and respiratory
syndrome virus
GC A GU G U UUA AAC
Berne virus G GGUG A U UUA AAC
Subterranean clover mottle virus C GAGC A U UUA AAC
Avian infectious bronchitis virus G AAUU A U UUA AAC
Human coronavirus C AGUU A U UUA AAC
Murine hepatitis virus G AACU U U UUA AAC
Severe acute respiratory syndrome
coronavirus
AA C GU U U UUA AAC
Human T-cell lymphotropic virus type 1 G UUCC C U UUA AAC
Simian T-cell lymphotropic virus type 1 G UUCC C U UUA AAC
Bovine leukaemia virus A UUCC C U UUA AAC
Human T-cell lymphotropic virus type 2 A UUUC C U UUA AAC
Cocksfoot mottle virus C CGGC C U UUA AAC
Potato leafroll virus C AAGC C U UUA AAU
Mason–Pﬁzer monkey virus (gag/pro) A UUUC A G GGA AAC
Simian type D virus 1 (gag/pro) C CAUC A G GGA AAC
Simian retrovirus type 2 (gag/pro) C CAUC A G GGA AAC
Visna virus (gag/pro) C CAUC A G GGA AAC
Feline immunodeﬁciency virus G AAUU C G GGA AAC
Beet western yellow virus U CUGU C G GGA AAC
Cereal yellow dwarf virus C GAGU C G GGA AAC
Cucurbit aphid-borne yellows virus C GAGU C G GGA AAC
Mason–Pﬁzer monkey virus C CAUG G A AAU UUU
Simian type D virus 1 A UUUG G A AAU UUU
Simian retrovirus type 2 A UUUG G A AAU UUU
Visna virus U UUUG G A AAU UUU
Barley yellow dwarf virus C UCUG U G GGU UUU
Peaenation mosaic virus RNA 2 C GCGG C G GAU UUU
The extended slippery sequence from eukaryotic viruses, A BCX XXY
YYZ, is indicated in bold (where the spaces correspond to the initial
reading frame). The sequences were retrieved from the RECODE
database (51). The nucleotides at position A BC are in italics. The
slippery sequences used in this study are underlined. Frameshift regions
are located at the viral gag/pol junction except when speciﬁed otherwise
(gag-pro).
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respectively, the P and A sites. After peptide bond
formation, the newly deac-tRNA and pept-tRNA in the
P and A sites become engaged in the translocation process.
Translocation begins after the binding of EF-G (or eEF2)
associated to a GTP molecule to the ribosome. After GTP
hydrolysis, the acceptor stems of the tRNAs move
towards the E and P sites, respectively, on the large
subunit (56). The tRNAs occupy hybrid sites, where the
acceptor stems of the tRNAs on the large ribosomal
subunit are in an intermediate position between the post-
and pre-translocational state (P/E
  and A/P
 , where the
star refers to a transition state). Such intermediate was
recently identiﬁed using single-turnover rapid kinetics
assays (57) (Figure 7A). The tRNA anticodon stem–
loops then move towards the E and P sites of the small
ribosomal subunit, occupying ﬁrst the intermediate
E
 /E
  and P
 /P
  sites. The next step is the movement
to the E/E and P/P sites, which drags the mRNA a
distance of three nucleotides (i.e. one codon), after release
of EF-G GDP from the ribosome. We propose that, for a
fraction of ribosomes, the two tRNAs cannot drag the
mRNA by three nucleotides, but only by two, due to the
presence of the stimulatory signal that is resistant to
unwinding. As a consequence, the two tRNAs are blocked
in intermediate E
 /E
  and P
 /P
  sites and translocation is
incomplete (Figure 7B). This hypothesis mainly relies on
the cryo-EM structure from Namy et al. (34), showing
that the presence of a frameshift stimulatory signal
stalls the ribosome in the translocation process. The next
step of translation is the arrival of an incoming aa-tRNA
bound to EF-Tu (or eEF1A) associated to a GTP
molecule. Because of the incomplete translocation, the
incoming aa-tRNA occupies an entry site (A
 /T
 ) that
diﬀers from the standard A/T entry site (Figure 7C).
Codon–anticodon interactions are dynamic and can break
and re-form. We propose that the tRNAs, which are
located in intermediate sites and not in their respective
Figure 7. The three tRNA -1 PRF model. The ﬁgure elements are as described in the legend to Figure 1. The unfolded lower stem of the HIV-1
stimulatory signal is represented by a wavy line and the stimulatory signal promoting the -1 PRF is the upper stem–loop, as explained in the text.
The elongation factor G (EF-G) and Tu (EF-Tu) are represented by a rectangular and an oval shape, respectively, and are either associated to a GTP
or to a GDP molecule. (A) After peptide bond formation and after the association of EF-G GTP to the ribosome and GTP hydrolysis, the acceptor
stem of the deac-tRNA and that of the pept-tRNA move towards the E and P sites, respectively, where they occupy intermediate P/E
  and A/P
 
sites on the ribosome. (B) The anticodon stems of the tRNAs move with the mRNA towards the E and P sites of the small ribosomal subunit. The
presence of the stimulatory signal limits the displacement of the mRNA to two bases instead of three, such that the deac-tRNA and the pept-tRNA
occupy, respectively, intermediate E
 /E
  and P
 /P
  sites. (C) The ribosome selects an incoming aa-tRNA in an A
 /T
  entry site. (D) The tRNAs in
the E
 /E
 ,P
 /P
  and A
 /T
  sites unpair from the mRNA, successively shift to the standard E, P and A/T sites and re-pair to the mRNA in the -1
reading frame. Note that whether there is pairing or not for the deac-tRNA occupying the standard E site is controversial (see the text).
(E) The deac-tRNA is ejected from the ribosome upon occupancy of the A/A site by the incoming aa-tRNA.
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shift to these standard sites, and, after the shift, re-pair to
the mRNA in the -1 reading frame (Figure 7D). The
driving force for the change in the reading frame is
therefore the tendency of the tRNAs to occupy their
standard binding sites. The slippage of the tRNAs would
start with the tRNA located in the E
 /E
  site, followed by
the successive slippage of the tRNAs located in the P
 /P
 
and A
 /T
  sites, towards the E/E, P/P and A/T sites
[see ref. (58) for the concept of successive tRNA slippage].
The -1 PRF would be followed by the aa-tRNA
accommodation in the A/A site, which is coupled with
the E-site tRNA ejection from the ribosome (59,60)
(Figure 7E) and conventional translation would resume
with unfolding of the frameshift stimulatory signal. In our
model, there are two steps where the ribosome pauses:
when it is blocked during translocation and when the three
tRNAs shift to their standard sites. As mentioned in the
‘Introduction’ section, Weiss et al. (26) were the ﬁrst to
suggest that -1 PRF was linked to translocation, but in
their model, -1 PRF occurs when the XXY and YYZ
codons occupy the P and A sites (Figure 1B). We suggest
that a translocation anomaly leading to -1 PRF occurs at
the preceding elongation cycle, when the BCX and XXY
codons occupy the P and A sites, which takes into account
the fact that the E-site codon participates in -1 PRF.
In our model, three tRNAs participate in -1 PRF. The
event is triggered by the blockade of the ribosome at a
transition state following an incomplete translocation due
to the presence of the stimulatory signal. How can we
explain that the identity of the BCX codon inﬂuences the -
1 PRF? It is well known that mutating the classic X XXY
YYZ motif prevents the slippage of the tRNAs located in
the P and A/T sites, since, after the shift, the tRNAs
cannot re-pair to the mRNA in the new reading frame.
However, whether there is a codon–anticodon interaction
at the E site is still a matter of debate. From the analysis of
crystal structures, no codon–anticodon interaction has
been observed between the mRNA and the deac-tRNA in
the E site (52,61). In contrast, in vitro translational
experiments support a codon–anticodon interaction at
the E site (60,62). From our slippery sequences analysis
(Table 1), it can be observed that, after -1 PRF, only one
standard base-pairing is possible between the tRNA and
the ABC nucleotides, in most cases. If there is a codon–
anticodon interaction at the E site, it could be suggested
that base pairs other than Watson–Crick or G-U wobble
pairs are tolerated at the E site. Under these relaxed
conditions, a major consequence of mutating the BCX
codon plus the preceding base is not likely to alter the -1
PRF eﬃciency by inﬂuencing the codon–anticodon inter-
action of the E-site tRNA in the shifted frame, although
minor eﬀects cannot be excluded. We propose that the
main consequence of making these changes is to modify
the identity of the E-site tRNA. Our hypothesis is that
there is a relationship between the structural peculiarities
of this tRNA and its capacity to shift from an inter-
mediate to a classic site, since the movement of this tRNA
precedes and thus controls the movement of the two
other tRNAs. The group of Rousset (63) had proposed
that, in -1 PRF, an E-site tRNA carrying a pseudouridine
modiﬁcation at position 39 was coupled to high -1 PRF
eﬃciency. However, these results could not be reproduced
(Rousset J.P. 2006, personal communication). Also, from
a search using the tRNA Compilation 2000 database (64),
our present results do not support any relationship
between the presence of a tRNA modiﬁcation at position
39 and the -1 PRF eﬃciency (data not shown).
In conclusion, we propose a novel model to describe -1
PRF, in which three tRNAs are involved. A detailed
understanding of -1 PRF mechanism should contribute to
the development of novel anti-frameshift agents that aﬀect
the replication capacity of viruses, such as HIV-1.
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